Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Stem Cell Res. 2012 Aug 19;9(3):249–260. doi: 10.1016/j.scr.2012.08.001

Figure 6.

Figure 6

Tumor-initiating capacity validating experiemnt. Xenotransplantation using 100 cells in Su86.86, Panc-1, and Human tumor K. Table A shows the number of tumors that grew per total number of sites injected. Each group was compared to the whole cell control with p-values listed. Table B shows combined analysis pooling numbers of tumors from all 3 cell lines and the comparisons between groups. Graph C shows the time to the development of a tumor combining all 3 cell lines together. SP/CD44-CD 24-CD326+ developed tumors more quickly than the CD44+CD24+CD326+ (p = 0.037).